Impact and reversal of life-threatening bleeds

Tuesday, April 27th, 2021 | 12:00 PM - 1:00 PM CT

This program will discuss the burden of life-threatening bleeds related to FXa inhibitors, and focus on the mechanism of action, efficacy and safety of reversal for patients on apixaban or rivaroxaban with life-threatening bleeding, as well as provide an overview of clinical guidelines for treating FXa inhibitor-related major bleeds.